Historical record - last NADAC effective date: 8/10/2015
Product Information
RESTORIL 15 MG CAPSULE is a brand product labeled by SpecGx LLC, priced at $19.8854 per EA under NDC 00406991601. Its NADAC has been published 100 times since Sep 17, 2014.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the temazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
SpecGx LLCNDC
00406991601
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/10/2015
Active Ingredients
TEMAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018163FDA Approved
Before 1982
TE Code
AB
On Market Since
2/27/1981
Pharmacological Classes
Price Statistics
The NADAC for RESTORIL 15 MG CAPSULE has been published 100 times since Sep 17, 2014, and over the history we have for it it has risen 58.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.8854 per EA |
|---|---|
| All-time high | $19.8854 (Aug 10, 2016) |
| All-time low | $12.5275 (Sep 17, 2014) |
| Median price | $19.8854 |
| Average price | $16.5427 |
| Largest weekly change | +50.0% (Aug 26, 2015) |
| Weeks tracked | 100 |
| Tracking since | Sep 17, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+58.7%
Last surveyed Aug 10, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RESTORIL 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RESTORIL 15 MG CAPSULE, manufactured by SpecGx LLC, is $19.8854 per EA (NDC 00406991601), effective Aug 10, 2016.
How has the price of RESTORIL 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RESTORIL 15 MG CAPSULE has risen 58.7%. It has been tracked across 100 weekly CMS publications since Sep 17, 2014.
What are the highest and lowest recorded NADAC prices for RESTORIL 15 MG CAPSULE?
Since Sep 17, 2014, the NADAC for RESTORIL 15 MG CAPSULE has ranged from a low of $12.5275 (Sep 17, 2014) to a high of $19.8854 (Aug 10, 2016), with a median of $19.8854 per EA.
Are there cheaper alternatives to RESTORIL 15 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TEMAZEPAM 15 MG CAPSULE, is $0.0791 per EA — about 99% below RESTORIL 15 MG CAPSULE.
Who manufactures RESTORIL 15 MG CAPSULE?
RESTORIL 15 MG CAPSULE (NDC 00406991601) is labeled by SpecGx LLC, and CMS classifies it as a brand product.